UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000031355
Receipt No. R000035798
Official scientific title of the study Impact of left atrial size on isolation area in the acute phase of pulmonary vein isolation using 28mm cryoballoon
Date of disclosure of the study information 2018/04/01
Last modified on 2018/02/18 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Impact of left atrial size on isolation area in the acute phase of pulmonary vein isolation using 28mm cryoballoon
Title of the study (Brief title) LA size in cryoballoon ablation
Region
Japan

Condition
Condition atrial fibrillation
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study evaluated the impact of the LA size on ISA in the PV antrum after PVI and compared ISA created using second-generation CB ablation and CF-guided RF ablation in the acute phase.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes We evaluated ISA after PVI using 3D-Merge computed tomography images and high-resolution electroanatomical mapping.
Key secondary outcomes Recurrence rate of atrial fibrillation after ablation

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Symptomatic, drug-refractory paroxysmal AF who were referred to Toyama Prefectural Central Hospital and National Hospital Organization, Kanazawa Medical Center in Japan between February 2017 and August 2017 for their first ablation procedure.
Key exclusion criteria We exclude patients who received catheter ablation without anatomocai CT merge
Target sample size 80

Research contact person
Name of lead principal investigator Akio Chikata
Organization Toyama Prefectural Central Hospital
Division name Division of Cardiology, Department of Internal Medicine
Address 2-2-78 Nishi-nagae, Toyama
TEL 076-424-1531
Email akio.chikata@gmail.com

Public contact
Name of contact person Akio Chikata
Organization Toyama Prefectural Central Hospital
Division name Division of Cardiology, Department of Internal Medicine
Address 2-2-78 Nishi-nagae, Toyama
TEL 076-424-1531
Homepage URL
Email akio.chikata@gmail.com

Sponsor
Institute Toyama Prefectural Central Hospital
Institute
Department

Funding Source
Organization Toyama Prefectural Central Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 04 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 01 Month 15 Day
Anticipated trial start date
2017 Year 02 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Using a 3D electroanatomical mapping system, this study evaluated the impact of the LA size on ISA in the PV antrum after PVI and compared ISA created using second-generation CB ablation and CF-guided RF ablation in the acute phase.

Management information
Registered date
2018 Year 02 Month 18 Day
Last modified on
2018 Year 02 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035798